ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 118 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,650,000 | +1.2% | 57,210 | +11.6% | 0.00% | 0.0% |
Q3 2016 | $1,630,000 | +0.7% | 51,246 | +2.7% | 0.00% | 0.0% |
Q2 2016 | $1,619,000 | -63.0% | 49,880 | -68.2% | 0.00% | -60.0% |
Q1 2016 | $4,380,000 | -62.1% | 156,651 | -51.6% | 0.01% | -58.3% |
Q4 2015 | $11,543,000 | +9.6% | 323,776 | +1.6% | 0.01% | +9.1% |
Q3 2015 | $10,534,000 | -15.7% | 318,536 | +6.7% | 0.01% | -15.4% |
Q2 2015 | $12,498,000 | +363.6% | 298,436 | +260.7% | 0.01% | +333.3% |
Q1 2015 | $2,696,000 | +7.2% | 82,736 | +4.5% | 0.00% | 0.0% |
Q4 2014 | $2,515,000 | +34.9% | 79,211 | +5.2% | 0.00% | +50.0% |
Q3 2014 | $1,864,000 | -85.2% | 75,292 | -86.5% | 0.00% | -83.3% |
Q2 2014 | $12,570,000 | -11.6% | 556,436 | -4.8% | 0.01% | -14.3% |
Q1 2014 | $14,222,000 | +10.6% | 584,541 | +13.6% | 0.01% | +16.7% |
Q4 2013 | $12,855,000 | -56.0% | 514,419 | -51.7% | 0.01% | -58.6% |
Q3 2013 | $29,242,000 | -36.6% | 1,064,509 | -58.1% | 0.03% | -39.6% |
Q2 2013 | $46,153,000 | – | 2,542,909 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |